Evaluate E1 Wear, Clinical Performance of E1 Liner in THA in Korean Patient Population

Ki vehet részt

• Patients will be included in this study if they received Ringloc acetabular system with E1 liner per the approved indications for use by KFDA in Korea. Specifically,
• Osteoarthritis
• Avascular necrosis
• Legg Perthes
• Rheumatoid Arthritis
• Diastrophic variant
• Fracture of the pelvis
• Fused hip
• Slipped capital epiphysis
• Subcapital fractures
• Traumatic arthritis Patients aged over 20 Patients with limited co-morbidity - ASA I - III

Ki nem vehet részt

• Absolute contraindications include: infection, sepsis, and osteomyelitis
• uncooperative patient or patient with neurologic disorders who are incapable of following directions,
• metabolic disorders which may impair bone formation,
• distant foci of infections which may spread to the implant site,
• vascular insufficiency, muscular atrophy, or neuromuscular disease
• Relative contraindications include:
• osteoporosis,
• osteomalacia,
• rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram, and
• pregnancy